Gemmer Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Gemmer Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-109	Closed	-$2K	–	1427
2014 Q4	$2K	Sell	109 -79	-42%	-$1.35K	﹤0.01%	1189
2014 Q3	$3K	Buy	188 +25	+15%	+$491	﹤0.01%	1073
2014 Q2	$3K	Sell	163 -29	-15%	-$596	﹤0.01%	1104
2014 Q1	$4K	Buy	+192	New	+$4.4K	﹤0.01%	992

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CPCM

Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Gemmer Asset Management's VIVO Position: Q1 2015 in Review

Gemmer Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2015, closing a stake of 109 shares — an estimated $2K sold.

Gemmer Asset Management first reported a position in VIVO in Q1 2014 and held it in 4 quarters. The position peaked at $4K in Q1 2014. 159 funds tracked by Wall St. Rank hold VIVO as of Q1 2015.

Gemmer Asset Management reported no remaining Meridian Bioscience Inc position as of Q1 2015 after selling out during the quarter.
Gemmer Asset Management sold 109 Meridian Bioscience Inc shares in Q1 2015, an estimated $2K.
Gemmer Asset Management first reported a position in Meridian Bioscience Inc in Q1 2014 and held it in 4 quarters.
Gemmer Asset Management's Meridian Bioscience Inc position peaked at $4K in Q1 2014.
159 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2015.

Based on Gemmer Asset Management's 13F filing for Q1 2015, filed 10 Apr 2015.